Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2015-07-30 08:08
Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the Board 2015-07-22 10:34
NetComm Wireless Wins ACOMM Award for Innovation for Fourth Consecutive Year 2015-07-17 10:08
Anisina Receives Orphan Drug Designation from FDA for Neuroblastoma 2015-07-16 15:37
Pre-clinical Studies Suggest Anisina May Improve Chemotherapy Effectiveness in Childhood Cancer 2015-07-14 07:00
Resverlogix Closes License Agreement and Enters Into Definitive Stock Purchase Agreement With Hepalink 2015-07-08 19:00
Novogen Announces the Chairman's Address at the Company's General Meeting 2015-06-24 10:54
Anisina on Track to Enter Clinic in 2016 2015-06-24 08:00
Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority 2015-06-22 19:30
Studies Confirm TRXE-009 Crosses the Blood-brain Barrier 2015-06-05 07:30
Novogen Expands Board with Two New Appointments 2015-06-03 09:20
Novogen Limited Announces Closing of Rights Issue Entitlement Offer and Notice of Shortfall 2015-06-02 11:47
Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 2015-06-01 19:30
ATM Technology Extended with New Patent Lodgement 2015-05-28 10:02
Novogen to Present at Brain Tumor Biotech Summit 2015 2015-05-27 06:00
Novogen to Present at the 2015 Marcum Microcap Conference 2015-05-26 08:28
NetComm Wireless Continues Its Global Expansion with Leading M2M Operators 2015-05-26 07:00
Pulse Evolution, Pioneers of Hologram and Virtual Reality Performance Industry to Present at Marcum MicroCap Conference in New York 2015-05-22 01:12
Anisina Confirmed as Effective Anti-Cancer Agent in Animal Studies 2015-05-14 09:39
Australian Studies Confirm TRXE-009 Kills Resistant Paediatric Brain Cancer Cells 2015-05-08 06:54
1 52 53 54 55 56